drugset / Trial / NCT02878291

Summary

The purpose of this study is to evaluate safety of meningococcal ACYW135 polysaccharide conjugate vaccine in healthy volunteers aged above 3 Months

Timeline

Start
2016-06
Primary completion
2016-11
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Meningococcal ACYW135 Polysaccharide Conjugate Vaccine Vaccine 20 ug Intramuscular
Subject Meningococcal ACYW135 Polysaccharide Conjugate Vaccine Vaccine 40 ug Intramuscular